Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight

Authors :: Maria S. Svane
Helle H. Johannesen
Adam E. Hansen
Christoffer Martinussen
Kirstine N. Bojsen-Møller
Martin Lundsgaard Hansen
Carolyn F. Deacon
Sune H. Keller
Thomas L. Klausen
Annika Loft
Andreas Kjaer
Johan Löfgren
Sten Madsbad
Jens J. Holst
Nicolai J. Wewer Albrechtsen
Source :: International Journal of Obesity. 46:2058-2062
Publication Year :: 2022
Publisher :: Springer Science and Business Media LLC, 2022.

Subjects :: Nutrition and Dietetics
Endocrinology, Diabetes and Metabolism
Medicine (miscellaneous)

Tools